MedPath

Comparison of midodrine with L -carnitine in the treatment of intradialytic hypotensio

Phase 3
Conditions
End Stage Renal Diesease.
Chronic kidney disease, stage 5
N18.5
Registration Number
IRCT20231223060507N1
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Dialysis patients of Namazi and Shahid Faqihi hospitals
At least two months have passed since they started dialysis
Dialyze at least twice a week
In more than 50% of dialysis sessions, intradialytic hypotension according to the variable definition of the plan

Exclusion Criteria

Intradialytic hypotension may be due to other reasons such as sepsis, untreated active cancer, heart failure...

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Intradialytic hypotension. Timepoint: After the end of the one-month treatment period, blood pressure is measured in both groups and the increase in blood pressure compared to the time before the study is checked. Method of measurement: Mercury sphygmomanometer.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath